In addition, the combination of LAG-3, PD-1, and Tim-3 enhances B-granzyme production by CD8+ tumor-infiltrating lymphocytes (TILs) and increases the cytotoxic activity of T lymphocytes against cancer cells [132]. Here, LAG3 is linked to neoplasm.